On the one hand, the fact that support policies such as benefits or allowance to low-income and low-education groups are effective but only slightly significant in a statistical way implies the necessity to consider other determinants than financial benefits.
Some studies have shown that prior experience in disaster situations was slightly significant in predicting the probability of evacuation (Bateman and Edwards 2002; Burnside et al. 2007; Adeola 2008; Lazo et al. 2015), while other studies found a negative or no significant relationship between past experience and relocation/evacuation willingness (Lindell et al. 2005; Lazo et al. 2010).
Although linkage disequilibrium was observed between P268S and the other three SNPs in NOD2, only P268S of the four variants was slightly significant in our study, which was consistent with recent study suggesting that P268S instead of 1007fs, G908R, R702W was a risk factor of Chinese Crohn's disease population.
In respect to the overall hypoglycemia rate, only the BEGIN Basal-Bolus T2 study 16 showed a slightly significant reduction in hypoglycemia in T2DM patients (−18%, P=0.0359).
Only in the group of AIPC with intrapancreatic involvement there was a slightly significant increase in the IgG4-CD138 ratin in comparison with non-autoimmune CP (p = 0.04).
Furthermore, and except for PC3 in which a slightly significant decrease in methylation levels was detected after treatment with DAC alone or combined with TSA (Dunnet's test, p = 0.027 and p = 0.012, respectively), no significant effects were found in methylation levels compared to mock cells in PCa cell lines, in line with bisulfite sequencing analysis results.
However, a slightly significant increase in the weight of placenta was seen in pregnant diabetic group treated with olive leaf extract (GIV) (0.132 ± 0.03) compared with that of GII.
Exemestane induced a non significant increase in the mean annual rate of BMD loss at lumbar spine with respect to placebo (2.17% vs 1.84%) and a slightly significant increase in femoral neck BMD (2.72% vs 1.48%; p = 0.02) (Lonning et al 2005).
Our first MassARRAY experiment with SQ2 suggested there were slightly significant differences in MI groups, while subsequent experiments with SQ1 and SQ3 were carried out to test the accuracy of SQ1 result, and results showed there were no differences in MI groups.
Slightly significant differences in the mean age were noted (53.0 [8.5] versus54.5[10.4]4] years old, respectively; t = 1.92, P = 0.06), and as such, the sample to whom the measures were administered was considered to be comparable to and representative of the population of FMS patients in the BSA database.
The recently published results of the X-ACT trial showed a slightly significant advantage in terms of 3 years risk of relapse (HR=0.87, CI 0.75 1.00) and of death (HR=0.84, CI 0.69 1.01) for patients treated with adjuvant capecitabine with respect to those treated with standard 5FU-FA (Twelves et al, 2005).
